Cannabigerolic acid (CBG-a)
Cannabichromenic acid (CBC-a); and,
♋Analgesic (relieves pain).
♋Anti-bacterial agent (slows growth of bacteria)
♋Anti-inflammatory (reduces inflammation systemically).
♋Anti-proliferative (Inhibits the growth of tumours / cancer cells). CBG-a has been found to encourage apoptosis, also known as programmed cell death. Defective apoptosis is believed to be a major reason for the formation and progression of cancer, research shows cannabinoids appear to stimulate apoptosis in previously unknown ways, posing a novel way to mitigate and potentially cure cancer.
CBG is a minor cannabinoid component in most varieties of cannabis, sometimes less than 1%. Nevertheless, narrow-leafleted strains from the Indian-subcontinent have been found to have slightly higher levels of CBG than others. Relatively high amounts of CBG can be extracted from budding plants about three-quarters of the way through flowering. CBG is not considered psychoactive and is known to block the psychoactive effects of THC.
♋Anti-insomnia - aids with sleep.
♋Anti-nausea - along with an anti-emetic (anti-vomiting) effect found in rats, although research has not yet been replicated in humans.
♋Anti-psoriatic - eases symptoms and treats psoriasis.
♋Bone stimulant (promotes bone growth)
♋Neurogenic - stimulates growth of new brain cells (CBG is the only cannabinoid identified that is neurogenic and neurogenic compounds are extremely rare, which makes CBG a worthwhile subject for research)
Hemp Edification February 2015 Cannabinoids